Company Performance Metrics
AIMA Diagnostics – AI-based Blood Diagnostics from Norway
AIMA Diagnostics is a Norwegian health tech company developing an advanced platform for precise and rapid blood diagnostics using artificial intelligence. By combining medical expertise with AI-powered algorithms, AIMA enables earlier disease detection, reduced error margins, and increased
efficiency in diagnostic processes for laboratories and clinics.
Our Technology AIMA applies machine learning and neural networks to analyze large volumes of blood test data, generating data-driven insights that support healthcare professionals in making faster and more accurate diagnoses. The platform functions as a digital decision support tool for laboratories and clinical institutions, both in Norway and internationally.
Why AIMA?
Reduces time and cost of analysis
Increases diagnostic accuracy and consistency
Scalable and compatible with existing lab infrastructure
Applicable in humanitarian projects and low-resource settings
A Norwegian Product with a Global Vision Founded in Norway by Sergey Smirnov, a Ukrainian entrepreneur with extensive experience in digital technology and the healthcare sector, AIMA is the result of a clear mission to revolutionize medical diagnostics through technology.
The company has submitted its first patent to the Norwegian Patent Office and is working with laboratories to implement and validate the platform in real-world settings.
Our Mission AIMA is committed to making advanced diagnostics accessible and efficient for all. We believe that accurate and early diagnostics save lives.
